Jun 22, 2010 - ... Ana Espinosa , Jelena Kolosnjaj-Tabi , Claire Wilhelm , Florence Gazeau .... Yongling Ding , Shirley Z. Shen , Huadong Sun , Kangning Sun ...
Several research groups have used AC-magnetic hyperthermia to trigger the release of magneto liposomes' payload by heating magnetic nanoparticles within ...
Aug 11, 2014 - The second standard release assay is based on the increase of the fluorescence signal from 5(6)-carboxyfluorescein dye when the dye is released from the magneto liposomes. The efficiency of drug release ... Citation data is made availa
Jun 22, 2010 - Division of Nanomaterials Science, EcoTopia Science Institute, Nagoya University, Furo-cho,. Chikusa-ku, Nagoya, 464-8603, Japan, and ...
Aug 11, 2014 - ... Drug Release from Magneto. Liposomes via Ultrasound Generation. George Podaru,. â . Saralyn Ogden,. â . Amanda Baxter,. â . Tej Shrestha,.
T1 relaxivity measurements were acquired using the same slice geometry and imaging matrix with a segmented fast low angle shot (FLASH) sequence with inversion recovery with inversion times of 50, 97, 186, 360, 695, 1341, 2590, and 5000 ... The magnet
Feb 20, 2015 - A robust and refillable magnetic sponge capsule for remotely triggered drug release. Jingru Shi , Hongbin Zhang , John Jackson , Ali Shademani , Mu Chiao. Journal of Materials Chemistry B 2016 4 (46), 7415-7422 ...
Jul 16, 2008 - Citation data is made available by participants in Crossref's Cited-by Linking service. For a more comprehensive list of citations to this article, ...
Dec 1, 2007 - Todd Hoare , Brian P. Timko , Jesus Santamaria , Gerardo F. Goya , Silvia Irusta , Samantha Lau , Cristina F. Stefanescu , Debora Lin , Robert ...
Feb 20, 2015 - Scott Campbell, Danielle Maitland, and Todd Hoare*. Department of Chemical Engineering, McMaster University, 1280 Main Street West, ...
Magnetic Field Stimuli-Sensitive Drug Release Using a Magnetic Thermal Seed Coated with Thermal-Responsive Molecularly Imprinted Polymer Takuya Kubo,*,† Kaname Tachibana,† Toyohiro Naito,† Sadaatsu Mukai,‡ Kazunari Akiyoshi,‡ Jeyadevan Balachandran,§ and Koji Otsuka†
ACS Biomater. Sci. Eng. Downloaded from pubs.acs.org by IOWA STATE UNIV on 01/12/19. For personal use only.
Department of Material Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto 615-8510, Japan ‡ Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto 615-8510, Japan § Department of Material Science, University of Shiga Prefecture, 2500 Hassaka-cho, Hikone City, 522-8533 Shiga Prefecture, Japan S Supporting Information *
ABSTRACT: A new stimulus-responsive drug delivery system using Fe3O4 nanoparticles coated with molecularly imprinted polymer (MIP) is reported. Magnetic thermal seeds (MTS) with their size controlled between 10 and 20 nm that could generate heat under an alternate current (AC) magnetic ﬁeld were modiﬁed with a thermalresponsive MIP by grafting polymerization for eﬀective release of an anticancer drug, methotrexate (MTX). The MIP-coated MTS showed the superparamagnetic property as well as the selective adsorption ability toward MTX, and 80% of MXT adsorbed on the MIP-coated MTS was stimulus released at 60 °C by cleaving hydrogen bonding in the recognition sites. Finally, the MTX release from the MTX-loaded MIP-coated MTS under an AC magnetic ﬁeld within 10 min was successfully demonstrated. KEYWORDS: magnetic thermal seed, molecularly imprinted polymer, stimuli-sensitive drug release, AC magnetic ﬁeld
hybridization with magnetic nanoparticles is predominant.17−20 These studies have revealed the possibility of directing MIP-based DDS to the targeting area. In general, magnetite nanoparticles with an average diameter of about 20 nm exhibit superparamagnetic property and possess considerable saturation magnetization to be directed to speciﬁc parts of the body using a weak external magnetic ﬁeld.21,22 Additionally, these magnetic nanoparticles interestingly generate heat under an alternate current (AC) magnetic ﬁeld due to the relaxation of its magnetic moment. Moreover, the amount of heat generated is controllable by modulating the strength of the magnetic ﬁeld and/or size of the nanoparticles.23,24 Consequently, the magnetite nanoparticles are employed as a magnetic thermal seed (MTS) in cancer therapy using magnetic hyperthermia.22,25 However, at present, the annihilation of cancer cells only by hyperthermia eﬀect is considered diﬃcult, and the concurrent use of anticancer drug treatment has been proposed. Thus, the development of novel DDS carrier that enables directivity toward the targeting area
Shizuoka, Japan) was used as a AC magnetic ﬁeld generator, and H103NR (Kokusan Co. Ltd. Saitama, Japan) was used as a centrifuge. Zetasizer Nano ZSP (Malvern Panalytical, Malvern, UK) was used for dynamic light scattering (DLS) measurements. 2.3. Preparation of MIP-MTS Hybrid Particles. 2.3.1. Preparation of Magnetic Nanoparticles. The Fe3O4-based magnetic nanoparticles were prepared by the coprecipitation method as well as using the previous procedures reported by the authors.24 Brieﬂy, iron(III) chloride hexahydrate of 2.16 g (8.0 mmol) and iron(II) chloride tetrahydrate of 0.97 g (4.9 mmol) were dissolved in 30 mL of pure water, and the mixture was treated by sonication. After nitrogen bubbling, the mixture was stirred at 700 rpm, and 0.74 M aqueous ammonia of 70 mL was dropped (15 drops/min). The Fe3O4 nanoparticles were collected by magnetic decantation and washed with pure water (3 times), and the collected particles were dispersed in methanol (MTS). 2.3.2. Modiﬁcation of Vinyl Groups. The Fe3O4 nanoparticles dispersed in methanol (23 mg in 2.4 mL methanol) with 225 μL of pure water were treated by sonication. TEOS of 16.8 μL and 25% aqueous ammonia of 120 μL were added to the Fe3O4 nanoparticle dispersion, and then the mixture was stirred by 800 rpm at 40 °C for 2 h. The particles were collected by magnetic decantation. These procedures were repeated three times. After addition of methanol of 5 mL, the mixture was stirred at 60 °C for 6 h. The collected TEOS modiﬁed nanoparticles (TEOS-MTS) of 10 mg were dispersed in 1.5 mL of water/methanol (1/9), and 45.0 μL of acetic acid and 35.8 μL of VTMS were added. The mixture was heated to 60 °C and stirred at 800 rpm for 24 h. After magnetic decantation, the collected nanoparticles were washed with methanol (3 times) and dried at 50 °C in vacuum (VTMS-MTS) 2.3.3. MIP Coated MTS. According to our previous study,39 thermal-responsive MIP for MTX was modiﬁed onto the prepared VTMS-MTS. As shown in Table 1, folic acid was employed as a
and the controlled release of the drug is still strongly required. Only a few researchers previously reported the application of MTS using a typical thermoresponsive polymer, poly(Nisopropylacrylamide).26−29 Recently, a variety of magnetically triggered nanomaterials has been reported for new stimulus drug releasing.30−33 In these reports, the kind of MTS was employed for the trigger of temperature increase, and the sensitive drug release was achieved for certain encapsulated molecules. These are suitable for a general method enabling drug release of variety of molecules. As a further possibility, the hybridization of MIP and MTS is more attractive for controlled drug releasing toward a targeting molecule. Griﬀete et al. showed the possibility of the hybridization of MTS and MIP for DDS;34 however, longer period was needed for increase in temperature and drug release. Additionally, Chen et al. reported the magnetic lysozyme-imprinted nanoparticles and their releasing property due to near-infrared light.35 These reports strongly showed the possibility to employ MIP and MTS as a new concept for stimulus drug releasing. Hence, to clarify the possibility of using MTS and MIP for DDS, further investigations are strongly required. In this article, the concept for the development of a new DDS carrier hybridizing thermal-responsive MIP with Fe3O4 nanoparticle has been proposed and experimentally veriﬁed. The use of MIP as a carrier for an anticancer drug, methotrexate (MTX, see Figure S1)36−38 has been already demonstrated by the authors.39 In this previous study, we simply showed the possibility of a thermoresponsive releasing of MTX using a typical MIP consisted of only organic polymer. Therefore, to achieve a self-drug release, the additional functions for leading and increase temperature are necessary. Here, the hybridization procedures for the development of thermosensitive DDS (MIP-MTS) that generates heat and also releases drug simultaneously is reported. Then, the selective adsorption/desorption of MTX on the prepared MIP-MTX is evaluated. Finally, the release of MTX from the MIP-MTS under an AC magnetic ﬁeld is also demonstrated.
Table 1. Components of the Prepared Hybrid Particles abbreviations
folic acid (mg)
MIP-MTS-1 NIP-MTS-1 MIP-MTS-2 NIP-MTS-2
3.9 − 3.9 −
2.9 10 5.9
2. MATERIALS AND METHODS 2.1. Chemicals and Reagents. Dimethyl sulfoxide (DMSO), folic acid, methanol (HPLC grade), phosphoric acid, sodium dihydrogen phosphate dehydrate, sodium hydroxide (NaOH), sodium hydrogen carbonate (NaHCO3), ethanol, acetic acid, and tetraethyl orthosilicate (TEOS) were purchased from Nacalai Tesque Inc. (Kyoto, Japan). 2,2′-Azobis(2,4-dimethylvaleronitrile) (ADVN), methotrexate (MTX), iron(III) chloride hexahydrate, iron(II) chloride tetrahydrate, polyethylene glycol 4000 (PEG4000), Nphthaloyl-L-glutamic acid, trimethoprim, and 25% ammonia solution were purchased from Wako Pure Chemical Industries (Osaka, Japan). Divinylbenzene (DVB), methacrylic acid (MAA), and vinyltrimethoxysilane (VTMS) were purchased from Tokyo Chemical Industry (Tokyo, Japan). DVB and MAA were puriﬁed by distillation at 43 °C at 7.0 Torr and 53 °C by 24 Torr, respectively. Deionized water was obtained from a Milli-Q Direct-Q 3UV system (Merck Millipore, Tokyo, Japan). 2.2. Instruments. The high performance liquid chromatography system consisted of a pump (LC-10ADvp), a degasser (DGU-14AM), a column oven (CTO-10ACvp), and a photodiode array detector (SPD-M10Avp) (Shimadzu Co. Kyoto, Japan). Thermomixer C (Eppendorf AG. Hamburg, Germany) was used as a shaker; Digital Homogenizer HOM (AS ONE Co. Tokyo, Japan) was used as a mechanical stirrer, and TM-VSM 1230-HHH5 (Tamakawa Co., LTD, Sendai, Japan) was used as a vibrating sample magnetometer. Nicolet iS5 ATR (Thermo Fisher Scientiﬁc Inc. Waltham, MA, United States) was used as a FT-IR spectrometer; T162-5723A (Thamway Co. Ltd.,
pseudo template molecule, MAA as a functional monomer, and DVB as a cross-linker. Following the contents in Table 1 and Figure 1, VTMS-MTS was dispersed in the mixture of folic acid, MAA, DVB, and DMSO as a porogenic solvent. After sonication for 10 min, the mixture was stirred at ambient conditions for 1 h to construct the
Figure 1. Chemical structure of methotrexate and others. B
ACS Biomaterials Science & Engineering Scheme 1. Schematic Image of the Preparation of Particles and Thermoresponsive Releasing
Figure 2. TEM images of the MTS and the modiﬁed-MTSs. (top row) Lower magnitude; (bottom row) higher magnitude. complex of folic acid and functional monomers. Then, ADVN was added as a radical polymerization initiator, and the mixture was stirred at 800 rpm at 40 °C for 24 h to complete the surface modiﬁcation of MIP layer onto VTMS-MTS. After polymerization, the particles were washed with acetic acid/methanol (1/9) to remove the template molecule (folic acid) and unreacted reagents. Finally, the particles were collected by magnetic decantation and dried under vacuum, and MIP-MTS were produced. Furthermore, the nonimprinted polymer coated MTS particles were also prepared by the same procedures without template molecules, and MIP-MTS were produced. For comparison with these hybrid particles, the typical MIP without any nanoparticles was also prepared by same composition of MIP-MTS-2 without MTS. The schematic image of the preparation of hybrid particles and its thermoresponsive molecular recognition is summarized in Scheme 1. 2.4. Adsorption and Desorption of MTX. MIP-MTS or NIPMTS particles were dispersed in 0.5−100 μM MTX (in DMSO/water = 6/4). Here, the concentration of the particles was adjusted to 5.0 mg/mL. The mixtures were stirred by 800 rpm at 25 °C for 24 h. After magnetic decantation, the concentrations of free MTX in supernatant were determined by HPLC analysis to estimate the amount of adsorbed MTX onto each particle. In addition, the collected MIP-MTS or NIP-MTS using a 50 μM MTX were washed with pure water (5 times) to remove the physically adsorbed MTX
and dried under vacuum for 48 h. The dried particles were redispersed in DMSO/water (6/4) of 5.0 mL and left at 60 or 25 °C for 24 h. After magnetic decantation, the free MTX was determined by HPLC to estimate the amount of released MXT. The HPLC conditions for determination of MTX are summarized as follows: column, YMC-Pack ODS-AM (150 mm × 4.6 mm i.d.) (YMC Co. Kyoto, Japan); mobile phase, (A) 10 mM phosphate buﬀer (pH 2.7), (B) methanol 20% B to 60% B for 6.0 min by linear gradient; temperature, 40 °C; detection, UV 300 nm. Calibration curve in HPLC analysis for MTX determination is indicated in Figure S1. The batch adsorption and desorption was considered by the following equation. Q = (Q 0 − C) × V /W
where Q is adsorption concentration of MTX on polymers (μmol/g), Q0 is MTX concentration of original solutions, C is MTX concentration after batch adsorption, V is volume of MTX solutions, and W is amount of polymers. 2.5. Evaluation of Magnetizing Properties. Magnetic properties of all the prepared particles were evaluated with a vibrating sample magnetometer. Furthermore, to conﬁrm the heat generation under AC magnetic ﬁeld, all the prepared particles were dispersed in a solvent and set at the center of handmade coil. After AC magnetic ﬁeld was applied (frequency, 600 kHz; strength of magnetic ﬁeld, 3.2 C
ACS Biomaterials Science & Engineering kA/m), the alteration of the temperature was evaluated, and the speciﬁc adsorption ratio (SAR) was estimated using the following equation. SAR = CS(mS /mi )(dT /dt )initial
conﬁrmed the increase in the intensity of the peak corresponding to Si−O. This was considered due to the formation of additional Si−O through the construction of VTMS. Additionally, the absorptions based on vinyl groups were also recorded around 1400 cm−1 (C−H bending) and 1600 cm−1 (CC stretching). The above observations conﬁrmed the eﬀective modiﬁcations by TEOS and VTMS. In addition, the polymer coated nanoparticles were also analyzed by FT-IR as shown in Figure S2, and all the MIPMTS showed spectra similar to an authentic MIP, which was simply prepared without any nanoparticles and expressed as ncMIP (noncomposited MIP). According to these spectral results, the successful modiﬁcation of MIP layer onto VTMSMTS by grafting polymerization was conﬁrmed. Furthermore, TEM images and the appearances by magnetic decantation of these MIP-MTS are shown in Figures 2 and 3. As shown in TEM images, the TEOS and VTMS coated MTS were still dispersible in methanol. In contrast, the MIP coated magnetite nanoparticles were slightly aggregated. The polymer layer was gradually grown by increasing the amount of cross-linker. On the other hand, although the color change was clearly observed due to the increase in MIP content, all the MIP-MTS were still eﬀectively collected by magnetic decantation. This conﬁrmed the coating of MIPs onto the VTMS-MTS. To conﬁrm the fraction of Fe3O4 particles and other layers, including TEOS, VTMS, and MIP, the magnetization of each sample was evaluated. The magnetization curve and saturation magnetization of each particle are summarized in Figure 4.
where CS is speciﬁc heat of the solvent, mS is amount of the solvent, mi is amount of magnetic particles, (dT/dt)initial is alteration of temperature per unit time
3. RESULTS AND DISCUSSION 3.1. Characterization of the Particles. We prepared the MIP-MTS by gradual modiﬁcations using TEOS and VTMS. The compositions of the layered MIPs and NIPs, which were prepared without any templates, are summarized in Table 1. TEM images in Figures 2 and 3 indicated that the
Figure 3. Physical appearance and magnetic decantation of MIPMTS. (left) Physical appearance and TEM image; (right) magnetic decantation; (upper) MTS; (middle) MIP-MTS-1; (lower) MIPMTS-2.
monodispersed Fe3O4 magnetic nanoparticles were successfully prepared. Additionally, the results of DLS observations for MTS and VTMS-MTS are summarized in Figure S3. Although DLS showed somewhat higher mean diameter that seemed to aggregate, by observation of these TEM images, the average diameter of the particles was estimated to be 11 nm, and its relative standard deviation was 20%. Figure 3 also shows the appearance during magnetic decantation. The results revealed that the nanoparticles were eﬀectively dispersed in methanol and possessed the anticipated magnetization, which was revealed by the settling of the particles out by a permanent magnet. To conﬁrm the surface modiﬁcation of Fe3O4 particles, the FT-IR spectra of hybrid particles containing TEOS-MTS and VTMS-MTS were obtained, and the results are shown in Figure S2. In the case of TEOS-MTS, peaks corresponding to speciﬁc absorptions of Fe−O and Si−O were observed around 600 and 1100 cm−1, respectively, suggesting the successful TEOS modiﬁcation. The comparison between the FT-IR proﬁles obtained for TEOS-MTS and VTMS-MTS
Figure 4. Magnetization curves for each nanoparticle.
Here, the weight fraction of Fe3O4 particles was estimated by comparing their saturation magnetization with the original Fe3O4 powder as shown in Table 2. According to Figure 4, original MTS and other three hybrid particles showed S shaped Table 2. Fraction of MTS Estimated from the Saturated Magnetization
ncMIP. Here, the compositions of MIP in MIP-MTS-2 was completely same as ncMIP, and the adsorption of MTX in original MTS was marginal. This can be due to diﬀerent molecular recognition mechanisms caused by the hybridization with the nanoparticles (VTMS-MTS) and MIPs. Brieﬂy, during the preparation of MIP-MTS, the template molecules ﬁrst interacted with the remaining silanol groups of TEOS on VTMS-MTS, and then the polymerization was carried out with additional functional monomer, methacrylic acid (MAA). Therefore, the recognition sites were rigidly constructed on the surface of the nanoparticles. Consequently, both the amount and selectivity for MTX were dramatically increased in MIP-MTS. Furthermore, the adsorbed amount of MTX in MIP-MTS-2 was twice that of MIP-MTS-1, and the imprinting factor was over 5.0. These signiﬁcant diﬀerences occurred simply due to diﬀerence in the amount of the MIP layer, while both NIP-MTS showed similar amount of MTX adsorption. Moreover, the adsorption selectivity for other related compounds was investigated to understand the selectivity for MTX and the molecular recognition mechanism in MIP-MTS. Usually, MIPs show cross selectivity for the structurally related compounds.40−44 Therefore, we investigated the adsorption selectivity for the compounds having structures with the similar moiety such as MTX, N-phthaloyl-L-glutamic acid, and trimethoprim (see Figure 1), which are analogues of glutamic acid and pteridine moiety, respectively. Batch adsorptions of these compounds for MIP-MTS-2 and NIP-MTS-2 were carried out, and the results are summarized in Figure S4. As expected, the imprinting factors for N-phthaloyl-L-glutamic acid and trimethoprim were 1.04 and 1.21, respectively. These results exhibited a slight enhancement in selective recognition of MIP for compounds structured with moieties similar to that of MTX. On the other hand, MIP-MTS-2 showed higher amount of MTX adsorption, and its imprinting factor was 5.04. Consequently, it is assumed that the signiﬁcantly higher recognition selectivity of MTX in MIP-MTS-2 was due to three-dimensionally recognized multiple interaction. Additionally, to know the quantitative binding strength toward MTX in MIP-MTS, the isotherm adsorptions were evaluated. To evaluate the binding properties, we employed Langmuir
curves and disappearance of hysteresis, suggesting superparamagnetic behavior. As expected, the saturated magnetization gradually decreased with the increase in the thickness of MIP layer. 3.2. Adsorption Selectivity. The amounts of MTX adsorption toward MIP-MTS, ncMIP, and Fe3O4 (MTS) are summarized in Figure 5. According to our previous study,39
Figure 5. Adsorption of MTX on MIP/NIP-MTS-2. The amount of MTX adsorbed and imprinting factor (IF) of MIP-MTS-2 using 5 μM MTX solutions. IF was calculated from the adsorbed amount of MIP and NIP; IF = AMIP/ANIP (AMIP, adsorption amount on MIP; ANIP, adsorption amount on NIP). The batch adsorption and desorption were evaluated by using the following equation: Q = (Q0 − C) × V/ W, where Q is adsorption concentration of MTX on the nanoparticle (μmol g−1), Q0 is MTX concentration of original solutions, C is MTX concentration after batch adsorption, V is volume of MTX solutions, and W is amount of the nanoparticles.
selective adsorption of ncMIP was conﬁrmed against ncNIP. Interestingly, the amount of adsorbed selectivity against the NIPs in each MIP-MTS was signiﬁcantly higher than that of
Figure 6. Scatchard plots of MIP-MTS-2 and NIP-MTS-2. The Scatchard plots are prepared using the Langmuir model and the following equation: Cb/Cf = nKP − KCb, where Cb, Cf, n, and K are the amount of bounded MTX, the free concentration of MTX in solution after the equilibrium, the number of the binding sites, and the binding constant with MTX, respectively. E
ACS Biomaterials Science & Engineering model and Freundlich mode to estimate a few parameters.45−47 Although Freundlich mode showed better linearity as shown in Figure S5, Langmuir model showed the typical results due to the imprinting sites, which usually show bimodal recognition sites containing high and low aﬃnity. The Scatchard plots of batch adsorption are shown in Figure 6, and the binding constants estimated by the Langmuir model are listed in Table S3. When NIP-MTS-2 was employed as adsorbent, lower binding constants (7.60 × 103 M−1) were estimated over a wide range of MTX concentrations. The adsorption behavior over the entire MTX concentrations could be explained using two binding constants. Similar behavior is observed in MIP studies;,48−52 in brief, the higher binding constant (1.18 × 105 M−1) of MIP-MTS-2 was 15 times that of NIP-MTS-2. The results clearly conﬁrmed the existence of selective molecular recognition sites in MIP-MTS-2. 3.3. Releasing MTX under High Temperature. Figure 7 showed the amount and ratio of the desorbed MTX under
3.4. Release by AC Magnetic Field. Table 4 shows the temperature variation using magnetic nanoparticles under AC Table 4. Temperature Alterations on MIP-MTS-2 alteration of temperature (°C) MTS TEOS-MTS MIP-MTS-1 MIP-MTS-2
22.6 9.3 3.1 1.8
16.3 4.75 1.8
magnetic ﬁeld. Here, the theoretical values of temperature alteration were calculated by using the amount of Fe3O4 particles. The actual temperature variations were slightly lower than the estimated theoretical values. This is assumed due to the heat loss caused by the modiﬁcation of Fe3O4 particles by TEOS, VTMS, and MIPs. To conﬁrm the heating phenomena of the Fe3O4 particles, the temperature variation against the concentration of the particles was measured, and the SAR values evaluated are summarized in Figure 8. Over the
Figure 7. Releasing of MTX on MIP/NIP-MTS-2. For the amount and ratio of released MTX from MIP-MTS-2, MTX was adsorbed on MIP- or NIP-MTS-2 with 50 μM MTX solution in advance, and then the amount of adsorbed MTX was estimated. After drying, the release was carried out in a MTX-free solvent at 25 or 60 °C for 10 or 60 min. Finally, the released MTX was estimated by determination of the concentration of MTX in supernatant.
Figure 8. Temperature alterations and SAR values on MTS.
concentration range considered, the theoretical linear relation between the MTS concentration and temperature variations was conﬁrmed. On the other hand, as shown in Figure S6, when MIP-MTS-2 was employed for the similar evaluations, a linear relation was not observed, especially at higher concentrations. At lower concentrations of MIP-MTS, a linear relationship was conﬁrmed, however, and with the increase in concentration, the temperature remained almost unchanged. As shown in the TEM image of MIP-MTS, the hybrid MIP particles were not monodispersed due to the aggregated morphology. Accordingly, it is assumed that the aggregation of each particle inhibited the theoretical heat dissipation. Therefore, to obtain the theoretical temperature increase in MIP-MTS under AC magnetic ﬁeld, the concentration should be under 25 mg/mL. Considering the results related to selective adsorption/ desorption of MTX and heating function in MIP-MTS, ﬁnally the drug release by simply applying AC magnetic ﬁeld was demonstrated. The released MTX was estimated using varying concentrations of MTX-adsorbed MIP-MTS-2. The results are summarized in Figure 9. The diﬀerence in the amount of MTX
variety of temperatures and soaking time. According to these results, increasing desorption ratios were observed in both MIP and NIP at higher temperatures. However, the desorption ratio of NIP was higher than that of MIP. It is inferred that MTX adsorbed on NIP weakly through hydrogen bonding with randomly arranged MAA in NIP, and 60 °C was enough to cleave most of the interactions. On the other hand, around 20% MTX remained in MIP-MTS-2 even at 60 °C, which indicated the existence of signiﬁcantly strong recognition sites in MIP. In the case of soaking time, MTX was completely released within 10 min at 60 °C, while the releasing was not completed at 25 °C even after 60 min. These results indicated that the multiple interactions due to through hydrogen bonding could be cleaved at higher temperature even in the case of MIP. Considering the above results, including the adsorption tests, the amount of MTX released was much higher in MIP-MTS-2 and is highly anticipated to be used for the eﬀective drug release by modulating the temperature. F
Figure 9. Releasing MTX from MIP-MTS-2 by AC magnetic ﬁeld. (a) Amount and (b) ratio of released MTX from MIP-MTS-2 with/without AC magnetic ﬁeld. The ratio was estimated from the adsorbed MTX on MIP-MTS-2 in advance.
released was clearly conﬁrmed under the presence and absence of AC magnetic ﬁeld. The results strongly suggested that the core Fe3O4 particles were heated by magnetic ﬁeld, and then the adsorbed MTX was eﬀectively cleaved from the MIP layer. On the other hand, the ratio of MTX released was almost same over 10 mg/mL of MIP-MTS-2 (Figure 9b), the reason being that the heating plateaued at higher concentration of MIPMTS, as observed in the heating test in Figure S6. Altogether, the power of magnetic ﬁeld was limited to make the particles heating in this case. Further eﬀective release was achieved by using higher AC magnetic ﬁeld. Consequently, the possibility of the concept using thermal-responsive MIP and magnetic thermal seed for eﬃcient drug release as a new DDS was successfully demonstrated.
T.K., K.A., B.J., and K.O. designed and conducted experiments for surface modiﬁcation and adsorption/releasing procedures. K.T., T.N., and S.M. performed the characterizations and analyzed data. Notes
The authors declare no competing ﬁnancial interest.
5. CONCLUSION In conclusion, a novel DDS concept using the hybrid material composed of magnetic-ﬁeld stimuli-sensitive seed (MTS) and a thermal-responsive MIP was experimentally veriﬁed as follows. The targeting drug, MTX, was selectively adsorbed on MIP-coated MTS through hydrogen bonding and desorbed by simply controlling the temperature by applying AC magnetic ﬁeld using the heat generating property of MTS that converts magnetic energy into thermal energy. The proposed concept can be eﬀectively used for a stimulus DDS by further optimizations containing the materials of MIPs and the strength of magnetic ﬁeld.
ACKNOWLEDGMENTS This research was partly supported by the Grant-in Aid for Scientiﬁc Research (Grants 25620111 and 15K13756) from the Japan Society for the Promotion of Science, an Environment Research and Technology Development Fund (5-1552) from the Ministry of the Environment, Japan, and JST CREST Grant JPMJCR17H2, Japan.
(1) Ansari, S.; Karimi, M. Novel developments and trends of analytical methods for drug analysis in biological and environmental samples by molecularly imprinted polymers. TrAC, Trends Anal. Chem. 2017, 89, 146−62. (2) Ashley, J.; Shahbazi, M. A.; Kant, K.; Chidambara, V. A.; Wolff, A.; Bang, D. D.; Sun, Y. Molecularly imprinted polymers for sample preparation and biosensing in food analysis: Progress and perspectives. Biosens. Bioelectron. 2017, 91, 606−15. (3) Bazin, I.; Tria, S. A.; Hayat, A.; Marty, J. L. New biorecognition molecules in biosensors for the detection of toxins. Biosens. Bioelectron. 2017, 87, 285−98. (4) Speltini, A.; Scalabrini, A.; Maraschi, F.; Sturini, M.; Profumo, A. Newest applications of molecularly imprinted polymers for extraction
S Supporting Information *
The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acsbiomaterials.8b01401. Calibration curve for MTX in HPLC, FT-IR spectra, DLS of the prepared nanoparticles, and temperature alterations by MIP-MTS-2 (PDF) G
in Fe3O4 nanoparticles for biomedical applications. Mater. Sci. Eng., C 2014, 42, 52−63. (24) Suto, M.; Hirota, Y.; Mamiya, H.; Fujita, A.; Kasuya, R.; Tohji, K.; Jeyadevan, B. Heat dissipation mechanism of magnetite nanoparticles in magnetic fluid hyperthermia. J. Magn. Magn. Mater. 2009, 321 (10), 1493−96. (25) Di Corato, R.; Béalle, G.; Kolosnjaj-Tabi, J.; Espinosa, A.; Clement, O.; Silva, A. K.; Menager, C.; Wilhelm, C. Combining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes. ACS Nano 2015, 9 (3), 2904−16. (26) Deshpande, S.; Sharma, S.; Koul, V.; Singh, N. Core-Shell Nanoparticles as an Efficient, Sustained, and Triggered Drug-Delivery System. ACS Omega 2017, 2 (10), 6455−63. (27) Tian, Z. F.; Yu, X.; Ruan, Z. J.; Zhu, M.; Zhu, Y. F.; Hanagata, N. Magnetic mesoporous silica nanoparticles coated with thermoresponsive copolymer for potential chemo- and magnetic hyperthermia therapy. Microporous Mesoporous Mater. 2018, 256, 1−9. (28) Wu, X. Q.; Wang, X. Y.; Lu, W. H.; Wang, X. R.; Li, J. H.; You, H. Y.; Xiong, H.; Chen, L. X. Water-compatible temperature and magnetic dual-responsive molecularly imprinted polymers for recognition and extraction of bisphenol A. J. Chromatogr. A 2016, 1435, 30−38. (29) Yu, L. X.; Dong, A. J.; Guo, R. W.; Yang, M. Y.; Deng, L. D.; Zhang, J. H. DOX/ICG Coencapsulated Liposome-Coated Thermosensitive Nanogels for NIR-Triggered Simultaneous Drug Release and Photothermal Effect. ACS Biomater. Sci. Eng. 2018, 4 (7), 2424−34. (30) Hoare, T.; Timko, B. P.; Santamaria, J.; Goya, G. F.; Irusta, S.; Lau, S.; Stefanescu, C. F.; Lin, D.; Langer, R.; Kohane, D. S. Magnetically triggered nanocomposite membranes: a versatile platform for triggered drug release. Nano Lett. 2011, 11 (3), 1395−400. (31) Omar, H.; Croissant, J. G.; Alamoudi, K.; Alsaiari, S.; Alradwan, I.; Majrashi, M. A.; Anjum, D. H.; Martins, P.; Laamarti, R.; Eppinger, J. Biodegradable magnetic [email protected] iron oxide nanovectors with ultralarge mesopores for high protein loading, magnetothermal release, and delivery. J. Controlled Release 2017, 259, 187−194. (32) Katagiri, K.; Ohta, K.; Sako, K.; Inumaru, K.; Hayashi, K.; Sasaki, Y.; Akiyoshi, K. Development and Potential Theranostic Applications of a Self-Assembled Hybrid of Magnetic Nanoparticle Clusters with Polysaccharide Nanogels. ChemPlusChem 2014, 79 (11), 1631−37. (33) Loiseau, E.; de Boiry, A. Q.; Niedermair, F.; Albrecht, G.; Rühs, P. A.; Studart, A. R. Explosive raspberries: controlled magnetically triggered bursting of microcapsules. Adv. Funct. Mater. 2016, 26 (22), 4007−15. (34) Griffete, N.; Fresnais, J.; Espinosa, A.; Wilhelm, C.; Bee, A.; Menager, C. Design of magnetic molecularly imprinted polymer nanoparticles for controlled release of doxorubicin under an alternative magnetic field in athermal conditions. Nanoscale 2015, 7 (45), 18891−96. (35) Chen, J.; Lei, S.; Xie, Y.; Wang, M.; Yang, J.; Ge, X. Fabrication of high-performance magnetic lysozyme-imprinted microsphere and its NIR-responsive controlled release property. ACS Appl. Mater. Interfaces 2015, 7 (51), 28606−15. (36) Shea, B.; Swinden, M. V.; Ghogomu, E. T.; Ortiz, Z.; Katchamart, W.; Rader, T.; Bombardier, C.; Wells, G. A.; Tugwell, P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. J. Rheumatol. 2014, 41 (6), 1049−60. (37) Baran, W.; Batycka-Baran, A.; Zychowska, M.; Bieniek, A.; Szepietowski, J. C. Folate supplementation reduces the side effects of methotrexate therapy for psoriasis. Expert Opin. Drug Saf. 2014, 13 (8), 1015−21. (38) Sukhotnik, I.; Geyer, T.; Pollak, Y.; Mogilner, J. G.; Coran, A. G.; Berkowitz, D. The role of Wnt/β-catenin signaling in enterocyte turnover during methotrexate-induced intestinal mucositis in a rat. PLoS One 2014, 9 (11), No. e110675. (39) Kubo, T.; Koterasawa, K.; Naito, T.; Otsuka, K. Molecularly imprinted polymer with a pseudo-template for thermo-responsive
of contaminants from environmental and food matrices: A review. Anal. Chim. Acta 2017, 974, 1−26. (5) Chen, L.; Wang, X.; Lu, W.; Wu, X.; Li, J. Molecular imprinting: perspectives and applications. Chem. Soc. Rev. 2016, 45 (8), 2137− 211. (6) Komiyama, M.; Mori, T.; Ariga, K. Molecular Imprinting: Materials Nanoarchitectonics with Molecular Information. Bull. Chem. Soc. Jpn. 2018, 91, 1075. (7) Culver, H. R.; Clegg, J. R.; Peppas, N. A. Analyte-Responsive Hydrogels: Intelligent Materials for Biosensing and Drug Delivery. Acc. Chem. Res. 2017, 50 (2), 170−78. (8) Gracias, D. H. Stimuli responsive self-folding using thin polymer films. Curr. Opin. Chem. Eng. 2013, 2 (1), 112−19. (9) Koetting, M. C.; Peters, J. T.; Steichen, S. D.; Peppas, N. A. Stimulus-responsive hydrogels: Theory, modern advances, and applications. Mater. Sci. Eng., R 2015, 93, 1−49. (10) Li, W.; Dong, K.; Ren, J. S.; Qu, X. G. A beta-LactamaseImprinted Responsive Hydrogel for the Treatment of AntibioticResistant Bacteria. Angew. Chem., Int. Ed. 2016, 55 (28), 8049−53. (11) Xu, S.; Lu, H.; Zheng, X.; Chen, L. Stimuli-responsive molecularly imprinted polymers: versatile functional materials. J. Mater. Chem. C 2013, 1 (29), 4406−22. (12) Dissanayake, S.; Denny, W. A.; Gamage, S.; Sarojini, V. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides. J. Controlled Release 2017, 250, 62−76. (13) Karimi, M.; Ghasemi, A.; Zangabad, P. S.; Rahighi, R.; Basri, S. M. M.; Mirshekari, H.; Amiri, M.; Pishabad, Z. S.; Aslani, A.; Bozorgomid, M.; Ghosh, D.; Beyzavi, A.; Vaseghi, A.; Aref, A. R.; Haghani, L.; Bahrami, S.; Hamblin, M. R. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem. Soc. Rev. 2016, 45 (5), 1457−1501. (14) Yin, Q.; Shen, J. N.; Zhang, Z. W.; Yu, H. J.; Li, Y. P. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor. Adv. Drug Delivery Rev. 2013, 65 (13−14), 1699− 715. (15) Kim, H.; Jo, A.; Baek, S.; Lim, D.; Park, S.-Y.; Cho, S. K.; Chung, J. W.; Yoon, J. Synergistically enhanced selective intracellular uptake of anticancer drug carrier comprising folic acid-conjugated hydrogels containing magnetite nanoparticles. Sci. Rep. 2017, 7, 41090. (16) Zheng, X.-F.; Lian, Q.; Yang, H.; Wang, X. Surface molecularly imprinted polymer of chitosan grafted poly (methyl methacrylate) for 5-fluorouracil and controlled release. Sci. Rep. 2016, 6, 21409. (17) Zhang, Z.; Zhang, X.; Liu, B.; Liu, J. Molecular imprinting on inorganic nanozymes for hundred-fold enzyme specificity. J. Am. Chem. Soc. 2017, 139 (15), 5412−19. (18) Li, X.; Zhang, B.; Li, W.; Lei, X.; Fan, X.; Tian, L.; Zhang, H.; Zhang, Q. Preparation and characterization of bovine serum albumin surface-imprinted thermosensitive magnetic polymer microsphere and its application for protein recognition. Biosens. Bioelectron. 2014, 51, 261−67. (19) Xu, C.; Shen, X.; Ye, L. Molecularly imprinted magnetic materials prepared from modular and clickable nanoparticles. J. Mater. Chem. 2012, 22 (15), 7427−33. (20) Xu, L.; Pan, J.; Dai, J.; Li, X.; Hang, H.; Cao, Z.; Yan, Y. Preparation of thermal-responsive magnetic molecularly imprinted polymers for selective removal of antibiotics from aqueous solution. J. Hazard. Mater. 2012, 233, 48−56. (21) De la Presa, P.; Luengo, Y.; Multigner, M.; Costo, R.; Morales, M.; Rivero, G.; Hernando, A. Study of heating efficiency as a function of concentration, size, and applied field in γ-Fe2O3 nanoparticles. J. Phys. Chem. C 2012, 116 (48), 25602−10. (22) Kolosnjaj-Tabi, J.; Di Corato, R.; Lartigue, L.; Marangon, I.; Guardia, P.; Silva, A. K.; Luciani, N.; Clément, O.; Flaud, P.; Singh, J. V. Heat-generating iron oxide nanocubes: subtle “destructurators” of the tumoral microenvironment. ACS Nano 2014, 8 (5), 4268−4283. (23) Sadat, M.; Patel, R.; Sookoor, J.; Bud’ko, S. L.; Ewing, R. C.; Zhang, J.; Xu, H.; Wang, Y.; Pauletti, G. M.; Mast, D. B. Effect of spatial confinement on magnetic hyperthermia via dipolar interactions H
ACS Biomaterials Science & Engineering adsorption/desorption based on hydrogen bonding. Microporous Mesoporous Mater. 2015, 218, 112−17. (40) Kubo, T.; Hosoya, K.; Otsuka, K. Molecularly Imprinted Adsorbents for Selective Separation and/or Concentration of Environmental Pollutants. Anal. Sci. 2014, 30 (1), 97−104. (41) Nemoto, K.; Kubo, T.; Nomachi, M.; Sano, T.; Matsumoto, T.; Hosoya, K.; Hattori, T.; Kaya, K. Simple and effective 3D recognition of domoic acid using a molecularly imprinted polymer. J. Am. Chem. Soc. 2007, 129 (44), 13626−32. (42) Shoji, R.; Takeuchi, T.; Kubo, I. Atrazine sensor based on molecularly imprinted polymer-modified gold electrode. Anal. Chem. 2003, 75 (18), 4882−86. (43) Takeuchi, T.; Hayashi, T.; Ichikawa, S.; Kaji, A.; Masui, M.; Matsumoto, H.; Sasao, R. Molecularly Imprinted Tailor-Made Functional Polymer Receptors for Highly Sensitive and Selective Separation and Detection of Target Molecules. Chromatography 2016, 37 (2), 43−64. (44) Takeuchi, T.; Mori, T.; Kuwahara, A.; Ohta, T.; Oshita, A.; Sunayama, H.; Kitayama, Y.; Ooya, T. Conjugated-Protein Mimics with Molecularly Imprinted Reconstructible and Transformable Regions that are Assembled Using Space-Filling Prosthetic Groups. Angew. Chem., Int. Ed. 2014, 53 (47), 12765−70. (45) Turiel, E.; Perez-Conde, C.; Martin-Esteban, A. Assessment of the cross-reactivity and binding sites characterisation of a propazineimprinted polymer using the Langmuir-Freundlich isotherm. Analyst 2003, 128 (2), 137−41. (46) Umpleby, R. J.; Baxter, S. C.; Chen, Y. Z.; Shah, R. N.; Shimizu, K. D. Characterization of molecularly imprinted polymers with the Langmuir-Freundlich isotherm. Anal. Chem. 2001, 73 (19), 4584−91. (47) Umpleby, R. J.; Baxter, S. C.; Rampey, A. M.; Rushton, G. T.; Chen, Y. Z.; Shimizu, K. D. Characterization of the heterogeneous binding site affinity distributions in molecularly imprinted polymers. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2004, 804 (1), 141−49. (48) Bhakta, S.; Seraji, M. S. I.; Suib, S. L.; Rusling, J. F. Antibodylike Biorecognition Sites for Proteins from Surface Imprinting on Nanoparticles. ACS Appl. Mater. Interfaces 2015, 7 (51), 28197−206. (49) Cai, X. Q.; Li, J. H.; Zhang, Z.; Yang, F. F.; Dong, R. C.; Chen, L. X. Novel Pb2+ Ion Imprinted Polymers Based on Ionic Interaction via Synergy of Dual Functional Monomers for Selective Solid-Phase Extraction of Pb2+ in Water Samples. ACS Appl. Mater. Interfaces 2014, 6 (1), 305−13. (50) Griffete, N.; Frederich, H.; Maitre, A.; Ravaine, S.; Chehimi, M. M.; Mangeney, C. Inverse Opals of Molecularly Imprinted Hydrogels for the Detection of Bisphenol A and pH Sensing. Langmuir 2012, 28 (1), 1005−12. (51) Hou, H. B.; Yu, D. M.; Hu, G. H. Preparation and Properties of Ion-Imprinted Hollow Particles for the Selective Adsorption of Silver Ions. Langmuir 2015, 31 (4), 1376−84. (52) Potyrailo, R. A. Polymeric sensor materials: Toward an alliance of combinatiorial and rational design tools? Angew. Chem., Int. Ed. 2006, 45 (5), 702−23.